Sean Grant, CFO of Vera Therapeutics ($VERA), made one open market sale of common shares in the last year, totaling $207,778. His most recent sale occurred on February 23, 2026. Among 11,678 insiders with sales, his activity ranks 8,336th by volume, well below the average of $8.6 million across 6.4 transactions. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 4949 | $41.98 | 119,181.0000 | 63,928,066 | 3.99% | 0.01% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 63,928,066 | 9999.99% | 0.08% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | A | Class A Common Stock | 25000 | $0.00 | 124,130.0000 | 63,928,066 | 25.22% | 0.04% |
| Feb. 18, 2025 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | A | Class A Common Stock | 26900 | $0.00 | 98,237.0000 | 0 | 37.71% | 0.00% |
| Feb. 18, 2025 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 53800 | $0.00 | 53,800.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 7361 | $39.25 | 72,570.0000 | 0 | 9.21% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 78 | $38.20 | 72,827.0000 | 0 | 0.11% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 80 | $39.22 | 72,747.0000 | 0 | 0.11% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 177 | $40.06 | 72,570.0000 | 0 | 0.24% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 387 | $38.22 | 72,570.0000 | 0 | 0.53% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 366 | $39.19 | 73,437.0000 | 0 | 0.50% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 867 | $40.06 | 72,570.0000 | 0 | 1.18% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 672 | $38.22 | 74,714.0000 | 0 | 0.89% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 639 | $39.19 | 74,075.0000 | 0 | 0.86% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 1505 | $40.06 | 72,570.0000 | 0 | 2.03% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 201 | $38.23 | 73,226.0000 | 0 | 0.27% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 203 | $39.20 | 73,023.0000 | 0 | 0.28% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 3112 | $38.22 | 82,479.0000 | 0 | 3.64% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 2944 | $39.19 | 79,535.0000 | 0 | 3.57% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 6965 | $40.06 | 72,570.0000 | 0 | 8.76% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | M | Stock Option (right to buy) | 99828 | $0.00 | 80,172.0000 | 0 | 55.46% | 0.00% |
| March 14, 2023 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | G | Class A Common Stock | 14285 | $0.00 | 59,297.0000 | 0 | 19.41% | 0.00% |
| March 14, 2023 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | G | Class A Common Stock | 14285 | $0.00 | 56,553.0000 | 0 | 33.80% | 0.00% |
| July 24, 2023 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | G | Class A Common Stock | 1620 | $0.00 | 59,933.0000 | 0 | 2.63% | 0.00% |
| Dec. 20, 2023 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | G | Class A Common Stock | 636 | $0.00 | 59,297.0000 | 0 | 1.06% | 0.00% |
| July 24, 2023 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | G | Class A Common Stock | 1620 | $0.00 | 59,297.0000 | 0 | 2.81% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 453 | $40.05 | 72,570.0000 | 0 | 0.62% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | M | Class A Common Stock | 99828 | $14.87 | 172,398.0000 | 0 | 137.56% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 69831 | $40.05 | 102,567.0000 | 0 | 40.51% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 10988 | $38.65 | 91,579.0000 | 0 | 10.71% | 0.00% |
| April 3, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | S | Class A Common Stock | 11648 | $38.13 | 79,931.0000 | 0 | 12.72% | 0.00% |
| Jan. 16, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 97500 | $0.00 | 97,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | Vera Therapeutics, Inc. | $VERA | Grant Sean | CHIEF FINANCIAL OFFICER | A | Class A Common Stock | 26250 | $0.00 | 88,683.0000 | 0 | 42.05% | 0.00% |
| June 23, 2023 | Vera Therapeutics, Inc. | $VERA | Grant Sean | Chief Financial Officer | P | Class A Common Stock | 5000 | $16.60 | 59,933.0000 | 0 | 9.10% | 0.00% |
| Feb. 15, 2023 | Vera Therapeutics, Inc. | $VERA | Grant Sean | Chief Financial Officer | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2023 | Vera Therapeutics, Inc. | $VERA | Grant Sean | Chief Financial Officer | P | Class A Common Stock | 14285 | $7.00 | 49,933.0000 | 0 | 40.07% | 0.00% |
| Feb. 6, 2022 | Vera Therapeutics, Inc. | $VERA | Grant Sean | Chief Financial Officer | P | Class A Common Stock | 14285 | $7.00 | 54,933.0000 | 0 | 35.14% | 0.00% |